Decrease in the levels of ngf and bdnf in brains of mice fed a tryptophan-deficient diet

Bioscience, Biotechnology and Biochemistry

Volumn 63, Issue 2, 1999, Pages 337-340

  Dong Ryulu, Lee ^a   Semba, Ritsuko ^b   Kondo, Hiromichi ^c   Goto, Schunko ^c   Nakano, Kiwao ^a  

^a NAGOYA UNIVERSITY   (Japan)

^b INSTITUTE FOR DEVELOPMENTAL RESEARCH   (Japan)

^c KINJO UNIVERSITY   (Japan)

Author keywords

Alzheimer s diseases; Astrocytes; Brain derived neurotrophic factor; Nerve growth factor; Tryptophan

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; NERVE GROWTH FACTOR; NEUROTROPHIN 3; TRYPTOPHAN;

ALZHEIMER DISEASE; ANIMAL; ARTICLE; BIOSYNTHESIS; BRAIN; BRAIN CORTEX; ENTORHINAL CORTEX; HIPPOCAMPUS; MALE; METABOLISM; MOUSE; SEPTUM PELLUCIDUM;

ALZHEIMER DISEASE; ANIMALS; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CEREBRAL CORTEX; ENTORHINAL CORTEX; HIPPOCAMPUS; MALE; MICE; NERVE GROWTH FACTORS; NEUROTROPHIN 3; SEPTUM PELLUCIDUM; TRYPTOPHAN;

EID: 0033073589     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.63.337     Document Type: Article

References (25)

1. Hefti, F., Hartikka, J., and Knusel, B., Function of neurotroph-ic factors in the adult and aging brain and their possible use in the treatment of neurodegenerative disease. Neurobiol. Aging, 10, 515-533 (1989).
2. Lindsay, R. M., Wiegand, S. J., Alter C. A., and Distephano, P. S., Neurotrophic factors: From molecule to man. Trends Neu-rosci., 17, 182-190 (1994).
3. Mufson, E. J., Both well, M., and Kor dower, J. H., Loss of nerve growth factor-immunoreactive neurons in Alzheimer’s diseases: A quantitative analysis across subregions of the basal forebrain. Exp. Neurol., 10, 221-232 (1989).
4. Appel, S. H., A unifying hypothesis for the cause of amyotrophic lateral sclerosis, Parkinsonism, and Alzheimer’s disease. Ann. Neurol., 10, 499-505 (1981).
5. Hefti, F., Is Alzheimer’s disease caused by lack of nerve growth factor? Ann. Neurol, 13, 109-110 (1983).
6. Connor, B., Young, D., Yan, Q., Faull R. L., Synek, B., and Dragunow, M., Brain-derived neurotrophic factor is reduced in Alzheimer’s disease. Mol. Brain Research, 49, 71-81 (1997).
7. Phillips, H. S., Hains, J. M., Armanini, M., Lamamee, G. R., Johnson, S. A., and Winslow, J. W., BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer’s disease. Neuron, 7, 695-702 (1991).
8. Olson, L., Nordberg, A., von Holst, H., Backman, L., and Ebendal, T., Nerve growth factor affects C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (case report), J. Neural. Transm. [P-D Sect], 4, 79-83 (1992).
9. Lee, D.-R., Kondod its metabolites in cultured mouse astroglial cells. Brain Research, 111, 228-230 (1997).
10. Lee, D.-R., Sawada, M., and Nakano, K., Stimulation of expression of nerve growth factor by tryptophan, H., Furukawa, S., and Nakano, K., Stimulation of NGF production by tryptophan an and its metabolite kynurenine in cultured mouse astroglial cells. Neuroscience Lett., 244, 17-20 (1998).
11. Gal, E. M. and Sherman, A. D., Synthesis and metabolism of L-kynurenine in rat brain. J. Neurochem., 30, 607-613 (1978).
12. Yokogoshi, H., Iwata, T., Ishida, K., and Yoshida, A., Effect of amino acid supplementation to low protein diet on brain and plasma levels of tryptophan and brain 5-hydroxyindoles in rats. J. Nutr., 117, 42-47 (1987).
13. Katoh-Semba, R., Takeuchi, I.K., Semba, R., and Kato, K., Distribution of brain-derived neurotrophic factor in rats and its changes with development in the brain. J. Neurochem., 69, 34-42 (1997).
14. Katoh-Semba, R., Semba, R., Kashiwamata, S., and Kato, K., Sex-dependent and sex-independent distribution of the β-subunit of nerve growth factor in the central nervous and peripheral tissues of mice. J. Neurochem., 52, 1559-1565 (1989).
15. Katoh-Semba, R., Kaisho, Y., Shintani, A., Nagahama, M., and Kato, K., Tissue distribution and immunocytochemical localization of neurotrophin-3 in the brain and peripheral tissues of rats. J. Neurochem., 66, 330-337 (1996).
16. Dowdy, S. and Wearden, S., Statistics for Research, Wiley, New York, pp. 262-274 (1983).
17. Canossa, M., Griesbeck, O., Berninger, B., Cmampana, G., Kolebeck, R., and Thoenen, H., Neurotrophin release by neu-rotrophins: Implications for activity-dependent neuronal plasticity. Proc. Natl. Acad. Sci. USA, 94, 13279-13286 (1997).
18. Marty, S., Berzaghi, M. P., and Berninger, B., Neurotrophins and activity-dependent plasticity of cortical interneurons. Trends Neurosci., 20, 198-202 (1997).
19. Shinoda, I., Furukawa, Y., and Furukawa, S., Stimulation of nerve growth factor synthesis by propentofylline in cultured mouse astroglial cells. Biochem. Pharmacol., 39, 1813-1816 (1990).
20. Takeuchi, R., Murase, K., Furukawa, Y., Frukawa, S., and Hayashi, K., Stimulation of nerve growth factor synthesis/secretion by 1,4-benzoquinone and its derivatives in cultured mouse astroglial cells. FEBS Lett., 261, 63-66 (1990).
21. Kawagishi, H., Ando, M., Sakamoto, H., Yoshida, S., Ojima, F., Ishiguro, Y., Ukai, N., and Furukawa, S. Hericenone C, D & E, stimulators of nerve growth factor (NGF) synthesis, from mushroom Hericium erinaceum. Tetrahed. Lett., 32, 4561-4564 (1991).
22. Furukawa, Y., Furukawa, S., Satoyoshi, E., and Hayashi, K., Catecholamines induce an increase in nerve growth factor content in the medium of mouse L-M cells. J. Biol. Chem., 261, 6039-6047 (1986).
23. Koehler, C., Ericksson, L. G., Okuno, E., and Schwarcz, R., Localization of quinolinic acid metabolizing enzymes in the rat brain. Immunohistochemical studies using antibodies to 3-hydroxyanthranilic acid oxygenase and quinolinic acid phos-phoribosyl transferase. Neuroscience, 27, 49-76 (1988).
24. Roberts, R. C., McCathy, K. E., Du, F., Okuno, E., and Schwarcz, R., Immunocytochemical localization of quinolinic acid synthesizing enzyme, 3-hydroxyanthranilic acid oxygenase, in the rat substantia nigra. Brain Research, 650, 229-238 (1994).
25. Report of the American Institute of Nutrition. Ad Hoc Committee on Standards for Nutritonal Studies. J. Nutr., 107, 1340-1348 (1977).